The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Aar, A. M.G.
Right arrow Articles by Teunissen, M. B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Aar, A. M.G.
Right arrow Articles by Teunissen, M. B. M.
The Journal of Immunology, 2007, 178: 1986-1990.
Copyright © 2007 by The American Association of Immunologists, Inc.

CUTTING EDGE

Cutting Edge: Loss of TLR2, TLR4, and TLR5 on Langerhans Cells Abolishes Bacterial Recognition1

Angelic M.G. van der Aar*, Regien M. R. Sylva-Steenland*, Jan D. Bos*, Martien L. Kapsenberg*,{dagger}, Esther C. de Jong2,{dagger} and Marcel B. M. Teunissen2,3,*

* Department of Dermatology and {dagger} Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
It is unknown whether closely related epidermal dendritic cells, Langerhans cells (LCs), and dermal dendritic cells (DDCs) have unique functions. In this study, we show that human DDCs have a broad TLR expression profile, whereas human LCs have a selective impaired expression of cell surface TLR2, TLR4, and TLR5, all involved in bacterial recognition. This distinct TLR expression profile is acquired during the TGF-beta1-driven development of LCs in vitro. Consequently, and in contrast to DDCs, LCs weakly respond to bacterial TLR2, TLR4, and TLR5 ligands in terms of cytokine production and maturation, as well as to whole Gram-positive and Gram-negative bacteria, whereas their responsiveness to viral TLR ligands and viruses is fully active and comparable to DDCs. Unresponsiveness of LCs to bacteria may be a mechanism that contributes to tolerance to bacterial commensals that colonize the skin.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Upon recognition of microbes, dendritic cells (DCs)4 produce inflammatory cytokines that induce innate responses and up-regulate their costimulatory molecules to promote adaptive immunity (1). Recognition of microbes is mediated by pattern recognition receptors (PRRs), including the TLR family (2). Bacterial ligands are mainly recognized by cell surface TLRs, for example, LPS is recognized by TLR4, lipids and peptidoglycans (PGNs) by the heterodimers TLR1/TLR2 and TLR2/TLR6, and flagellin by TLR5. Alternatively, viral compounds trigger endosome-associated receptors, such as TLR3 by dsRNA, TLR7 and TLR8 by ssRNA, and TLR9 by unmethylated CpG DNA. Healthy normal human skin contains two distinct major subsets of resident DCs, both of myeloid origin (3): Langerhans cells (LCs) form a three-dimensional network in the epidermis (1, 4) and dermal DCs (DDCs) are located in the dermis usually around capillary vessels (5). LCs can phenotypically be distinguished from DDCs by the expression of Langerin, E-cadherin, and unique intracellular organelles called Birbeck granules (1, 3). Most of the phenotypic characteristics of LCs depend on TGF-beta1 present in the epidermal microenvironment (6), and the observation that TGF-beta1 knockout mice are devoid of LCs further establishes that TGF-beta1 is crucial for the development of LCs (7, 8). Accordingly, TGF-beta1 determines the differentiation of peripheral blood monocytes into LC-like cells (9, 10). To date, it is unknown whether LCs and DDCs have different roles in immunity and tolerance. In this study, we report that LCs, in contrast to DDCs, have a remarkable, strongly impaired expression of cell surface TLR2, TLR4, and TLR5, resulting in a selective low reactivity to bacteria. This attenuated reactivity of LCs to bacteria may be a mechanism contributing to tolerance to the bacterial commensal skin flora.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Isolation of DDCs and LCs and in vitro generation of DDC-like and LC-like cells

Epidermal and dermal cell suspensions were obtained from residual skin obtained from plastic surgery as described previously (11, 12). Overnight incubation at 4°C in 0.2% dispase II (Boehringer Mannheim) enabled separation of epidermis and dermis, whereafter epidermal sheets were incubated in 0.25% trypsin solution (5 min at 37°C; Invitrogen Life Technologies), and dermal sheets in IMDM containing 0.2% collagenase D (Boehringer Mannheim), 40 U/ml DNase I (Boehringer Mannheim), and 2% FCS for 2 h at 37°C to yield single cells. After labeling with fluorescent-conjugated mAbs, (BD Biosciences), highly pure (>95%) CD1a+HLA-DR+ LCs and CD3–CD14–HLA-DR+CD11c+CD45+ DDCs were isolated by FACS sorting (BD Biosciences). Monocyte-derived DCs (moDCs) were generated by culture of peripheral blood monocytes in medium supplemented with IL-4 and GM-CSF (13), whereas additional supplementation with 10 ng/ml TGF-beta1 (R&D Systems) resulted in monocyte-derived LCs (moLCs) (9).

Stimulation of DCs

Immature moDCs and moLCs were stimulated at a density of 3.5 x 104 cells in a 96-well culture plate with TLR agonists, UV-inactivated bacteria (range 105–107), or heat-inactivated viruses (30 min, 56°C). TLR agonists used were as follows: LPS (Escherichia coli), PGN (Staphylococcus aureus), and dsRNA (poly(deoxyinosinic-deoxycytidylic acid)) from Sigma-Aldrich. PAM3CSK4, ssRNA (LyoVec), resiquimod (R848), flagellin (Salmonella typhimurium), lipoteichoic acid (S. aureus), and FSL were purchased from InvivoGen. Cytokine levels were analyzed by ELISA and the expression of maturation markers CD86 and CD83 by FACS (13). Gram-negative bacteria: E. coli B12G1 (14), Klebsiella pneumoniae (clinical isolate), Neisseria meningitidis H44/76 (14), and Gram-positive bacteria: S. aureus 42D (15), Corynebacterium xerosis (clinical isolate), and Enterococcus faecalis 19916 (15) were provided by S. A. J. Zaat (Department of Microbiology, Academic Medical Center, Amsterdam, The Netherlands). Varizella Zoster virus and CMV were provided by H. W. M. van Eijk (Department of Clinical Virology, Academic Medical Center). Influenza virus (FLU) A/PR/8/34 was a gift from G. Rimmelzwaan (Department of Virology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands). The titers of virus were FLU A, 1.16 x 1010/ml; Varizella Zoster virus, 6.36 x 107/ml, and CMV, 1.07 x 108, determined by quantitative RT-PCR (16).

Real-time quantitative RT-PCR analysis

moLCs were purified (>98%) by FACS sorting (BD Biosciences) based on CD1a and E-cadherin expression, and moDCs were sorted based on forward side scatter. mRNA was extracted (isolation kit from Machery-Nagel) and cDNA transcripts (MBI Fermentas) were quantified by real-time quantitative PCR (iCycler iQ MultiColor Real-Time PCR Detection System; Bio-Rad) with specific primers (17) and general SYBR green (Bio-Rad) fluorescence detection. mRNA expression of each sample was normalized to GAPDH (18).

Statistics

We performed Wilcoxon or Student t tests for paired measurements with GraphPad software (GraphPad InStat). Values of p < 0.05 were considered significant.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
LCs have a strongly impaired expression of bacteria-recognizing TLRs

When analyzing highly purified ex vivo DDCs and LCs (Fig. 1A), we found that DDCs expressed TLR1 through TLR8, but surprisingly, LCs expressed TLR1, TLR3, TLR6, and TLR7, whereas the expression of TLR2, TLR4, TLR5, and TLR8 was weak or even absent (Fig. 1B). Both DDCs and LCs did not express TLR9 and TLR10. Quantitative RT-PCR confirmed the significantly lower expression of TLR2, TLR4, TLR5, and TLR8 by LCs (Fig. 1C). No significant differences in TLR1 and TLR3 expression were found, whereas TLR6 expression was significantly higher in LCs than in DDCs. However, it may be expected that TLR1 and TLR6 expression in LCs is not functional because these TLRs form heterodimers with TLR2, which is absent in LCs. These data clearly indicate that LCs lack expression of functional TLRs involved in the recognition of bacterial components.


Figure 1
View larger version (51K):
[in this window]
[in a new window]

  		FIGURE 1. Differential expression of TLR mRNA by DDCs and LCs. A, Characterization of DDCs and LCs isolated from skin. B, DDCs (upper panel) express TLR1 through TLR8, whereas LCs (lower panel) express no or low amounts of TLR2, TLR4, and TLR5. C, Quantification of TLR expression by DDCs ({blacksquare}) and LCs ({square}). TLR mRNA expression relative to GAPDH mRNA was determined by quantitative real-time RT-PCR and is depicted as arbitrary units. Freshly isolated LCs show a significantly lower expression of TLR2, TLR4, TLR5, and TLR8 than DDCs. Results are shown as means ± SD (n = 4) (*, p < 0.05; **, p < 0.01; ***, p < 0.001).

 
TLR expression by moDCs and moLCs is similar to their in vivo counterparts

MoDCs and moLCs, generally considered as equivalents of LCs and DDCs, typically exhibited the phenotype of immature DCs (CD14–, CD1a+/–, HLA-DR+, CD83–, and CD86low), and moLCs could be discriminated by expression of E-cadherin and Langerin (data not shown). The TLR expression profiles of FACS-purified moDCs and moLCs (Fig. 2A) were similar to those of ex vivo DDCs and LCs, respectively. Compared with moDCs, moLCs expressed significantly lower levels of TLR2, TLR4, TLR5, and TLR8, nonsignificantly lower levels of TLR7, similar levels of TLR1 and TLR3, and significantly enhanced levels of TLR6 mRNA (Fig. 2B). This phenotypical similarity strongly suggests that TGF-beta1 plays an important role in the differential TLR expression profile of LCs and DDCs.


Figure 2
View larger version (58K):
[in this window]
[in a new window]

  		FIGURE 2. TLR expression of by moDCs and moLCs. A, moDCs (upper panel) express TLR1 through TLR8, whereas moLCs (lower panel) express no or low amounts of TLR2, TLR4, TLR5, and TLR7. B, Quantification of expressed TLR by moDCs ({blacksquare}) and moLCs ({square}) by quantitative real-time RT-PCR. TLR mRNA expression relative to GAPDH mRNA is depicted as arbitrary units. Expression of TLR2, TLR4, TLR5, and TLR8 by moLCs is significantly lower compared with moDCs. Results are shown as means ± SD of four healthy donors (*, p < 0.05;**, p < 0.01; ***, p < 0.001).

 
LCs have an impaired responsiveness to bacteria-derived TLR agonists

To test whether their different TLR expression profile results in different responses to microbial compounds, moDCs and moLCs were stimulated with various specific TLR agonists at different concentrations (Fig. 3) for different periods of time (data not shown). Ligation of intracellular TLRs induced equal levels of IL-6 and IL-12p70 production in moDCs and moLCs (Fig. 3A). In these experiments, TNF-{alpha} production was significantly increased in moLCs upon TLR3 ligation. In notable contrast, the bacterial-derived agonists LPS (TLR4), flagellin (TLR5), Pam3CSK4 (TLR2/TLR1), lipoteichoic acid (TLR2; data not shown), and FSL (TLR2/TLR6; data not shown) induced a substantially lower IL-6 and TNF-{alpha} production by moLCs compared with moDCs at all concentrations (Fig. 3B). None of the extracellular TLR agonist induced detectable levels of IL-12p70 by moDCs and moLCs. These results stress that the strongly reduced expression of cell surface TLRs by LCs has the functional consequence that these cells are unable to recognize bacterial components. The only exception was PGN, which induced considerable TNF-{alpha} production in moLCs (Fig. 3B). Notably, no significant effect of TGF-beta1 on the responsiveness to microbial compounds was observed when this cytokine was present during TLR triggering of moLCs and moDCs, regardless of which TLR was stimulated (data not shown). This indicates that the TGF-beta1-driven loss of bacteria recognizing TLRs is accomplished during the differentiation of moLCs from their precursors, whereas the actual responsiveness of differentiated DCs to TLR ligands is not affected by presence of TGF-beta1. In line with the cytokine responses, bacterial-derived agonists, with the exception of PGN, failed to induce expression of the maturation markers CD86 (Fig. 3C) and CD83 (data not shown) in moLCs, but not in moDCs, whereas both DC subsets acquired a mature phenotype after triggering with intracellular TLRs.


Figure 3
View larger version (42K):
[in this window]
[in a new window]

  		FIGURE 3. Impaired reactivity of moLCs to extracellular TLR agonists. Immature moDCs ({blacksquare}) and moLCs ({square}) were stimulated with a serial dilution of TLR agonists and IL-6, TNF-{alpha}, and IL-12p70 concentration was measured in 24-h culture supernatants (A and B). Results are expressed as means ± SD of triplicate cultures of one representative experiment of six independent experiments (*, p < 0.05; **, p < 0.01; ***, p < 0.001); ND, None detected. The same results were obtained after 12 and 48 h of stimulation (data not shown). C, Surface expression on CD86 immature moDCs and moLCs before (open histograms) and after stimulation with TLR agonists (filled histograms). Similar results were obtained with CD83 (data not shown). Results are representative of three independent experiments.

 
LCs have an impaired responsiveness to bacteria compared with DDCs

The inability to respond to bacterial TLR ligands strongly suggests that LCs may be unable to respond to whole bacteria. Therefore, we tested the responsiveness of moDCs and moLCs to whole bacteria and viruses using the production of IL-12, IL-6, and TNF-{alpha} as read out (Fig. 4, A and B). In sharp contrast to moDCs, moLCs produced no or significantly lower amounts of cytokines in response to Gram-positive and Gram-negative bacteria (Fig. 4A). No difference was found in the responsiveness of moDCs and moLCs to viruses (Fig. 4B). Furthermore, whole bacteria were unable to induce maturation in moLCs at all tested concentrations but did so in moDCs, whereas the FLU virus induced CD86 (Fig. 4C) and CD83 (data not shown) in both moLCs and moDCs. These results clearly show that moLCs have an impaired reactivity to bacteria, while their ability to react effectively to viruses remained fully operational.


Figure 4
View larger version (55K):
[in this window]
[in a new window]

  		FIGURE 4. Impaired reactivity of moLCs to whole bacteria. Cytokine production (A and B) by moDCs ({blacksquare}) and moLCs ({square}) stimulated with a panel of Gram-positive bacteria, Gram-negative bacteria, and viruses. Cytokine levels were measured in 24-h culture supernatants by ELISA. Results are presented as mean ± SD of three replicates of one representative experiment of eight (*, p < 0.05; **, p < 0.01; ***, p < 0.001); ND, None detected. C, Surface expression of CD86 on immature moDCs and moLCs (open histograms) and after 24 h of coculture with whole bacteria (107) and FLU (1/100) (filled histograms). Results are representative of two independent experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
This study shows for the first time that LCs, compared with DDCs, do not efficiently respond to Gram-positive and Gram-negative bacteria, which may be linked to their distinct TLR expression profile. Whereas DDCs express a broad TLR spectrum, LCs lack the expression of cell surface TLRs involved in bacterial recognition. The TLR expression patterns of moDCs and moLCs closely matched the TLR profile of their ex vivo equivalents. The resemblance stresses the validity of moDCs and moLCs as models for their counterparts in human skin. Since monocytes do express TLR2, TLR4, and TLR5 (19, 20, 21) and the development of moLC and moDC depends on the presence or absence of TGF-beta1 in cultures of the same pool of monocytes, the experiments suggest that TGF-beta is a key molecule in determining the inability of LCs to recognize bacteria. LCs displayed a strongly diminished production of cytokines and up-regulation of maturation markers CD83 and CD86 in response to specific ligands for TLR2, TLR4, and TLR5, confirming the impaired expression of these TLRs. PGN formed the only exception because this ligand triggered LCs to produce TNF-{alpha} and to express CD83 and CD86. This reactivity may result from weak TLR2 expression by LCs. However, PGN also triggers other PRRs, such as NOD2 and NALP3, resulting in TNF-{alpha} production (22, 23, 24). Indeed, moLCs expressed NOD2 mRNA at a comparable level as moDCs (data not shown), indicating that moLCs can respond to PGN via other pathways. The significance of the reactivity to PGN remains to be established since LCs do not respond to whole bacteria. The differential responsiveness to single TLR agonists and whole bacteria may be explained by the fact that bacteria trigger multiple PRRs, which may amplify as well as inhibit responses to single TLR agonists (25). In contrast to the impaired bacterial recognition, we showed that LCs are fully responsive to viruses. However, it is not clear yet whether LCs are the actual inducers of antiviral immunity because two studies with in vivo models on epithelial HSV infection argue against a role for LC in direct priming of protective antiviral-specific T cells (26, 27).

Our findings are in line with a study by Takeuchi et al. (28), reporting that human moLCs have low TLR2 and no TLR4 expression and respond weakly to PGN and not to LPS. However, this study did not detail on the questions to what extend LCs do respond to other TLR ligands and, more importantly, whether these cells differentially respond to whole microorganisms. Another study (29) reported that LC-like cells derived from CD34+ cord blood cells express TLR1–10, which is not in line with our study and the study by Takeuchi et al. (28). The validity of cord blood-derived LC-like cells as a model of LCs in this study is unclear because these cells were not purified, and their TLR profile is dissimilar to the TLR profile of authentic human LCs.

The inability of LCs to respond efficiently to bacteria, as shown in this study, implicates that the presence of bacteria will not easily provoke LC-mediated local inflammation and onset of specific immunity. This impaired reactivity and maturation of LCs may be a mechanism that contributes to immunological tolerance to commensal bacteria of the skin. In addition, uptake of bacteria by LCs in the absence of TLR activation could result in specific tolerance induction since studies in mice have demonstrated that immature or semimature DCs, that do not produce polarizing cytokines, induce Ag-specific tolerance (30, 31). However, bacteria that are successful in colonizing the more vulnerable dermal layer of the skin will readily trigger DDCs, even in the presence of TGF-beta1. LCs are generally referred to as the first immunological barrier against pathogens. The impaired reactivity of LCs to bacteria suggests that this is only partially true. We propose that constitutive production of TGF-beta in the epidermis creates an immunopriviliged compartment through the enforcement of a unique DC phenotype associated with selective tolerance to extracellular bacteria. This prevents unnecessary inflammation in response to harmless skin commensals while preserving responsiveness to intracellular pathogens.


   Acknowledgments
 
We thank B. Hooibrink, M. E. Valk-Lingbeek, T. M. M. van Capel, and R. Westland for technical assistance and Dr. H. G. M. Niesters for determination of virus titers.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Netherlands Institute for Pigment Disorders. Back

2 E.C.d.J. and M.B.M.T. contributed equally to this work. Back

3 Address correspondence and reprint requests to Dr. Marcel B. M. Teunissen, Department of Dermatology, University of Amsterdam, Academic Medical Center, Meibergdreef 9, 1105AZ Amsterdam, The Netherlands. E-mail address: m.b.teunissen{at}amc.uva.nl Back

4 Abbreviations used in this paper: DC, dendritic cell; LC, Langerhans cell; DDC, dermal DC; PRR, pattern recognition receptor; moDC, monocyte-derived DC; moLC, monocyte-derived LC; PGN, peptidoglycan; FLU, influenza virus. Back

Received for publication November 6, 2006. Accepted for publication December 11, 2006.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Banchereau, J., R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. [Medline]
  2. Akira, S., K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. [Medline]
  3. Teunissen, M. B.. 2005. Langerhans cells and other skin dendritic cells. J. D. Bos, ed. Skin Immune System (SIS): Cutaneous Immunology and Clinical Immunodermatology 123-182. CRC Press, Boca Raton.
  4. Rowden, G., M. G. Lewis, A. K. Sullivan. 1977. Ia antigen expression on human epidermal Langerhans cells. Nature 268: 247-248. [Medline]
  5. Nestle, F. O., L. Filgueira, B. J. Nickoloff, G. Burg. 1998. Human dermal dendritic cells process and present soluble protein antigens. J. Invest. Dermatol. 110: 762-766. [Medline]
  6. Strobl, H., W. Knapp. 1999. TGF-beta1 regulation of dendritic cells. Microbes Infect. 1: 1283-1290. [Medline]
  7. Borkowski, T. A., J. J. Letterio, A. G. Farr, M. C. Udey. 1996. A role for endogenous transforming growth factor beta1 in Langerhans cell biology: the skin of transforming growth factor beta1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184: 2417-2422. [Abstract/Free Full Text]
  8. Thomas, R. M., D. V. Belsito, C. Huang, L. Z. Chen Lz, I. Ormsby, W. J. Simmons, P. Cowin, J. Shaw, T. Doetschman, G. J. Thorbecke. 2001. Appearance of Langerhans cells in the epidermis of Tgfb1–/– SCID mice: paracrine and autocrine effects of transforming growth factor-beta1 and -beta2(1). J. Invest. Dermatol. 117: 1574-1580. [Medline]
  9. Geissmann, F., C. Prost, J. P. Monnet, M. Dy, N. Brousse, O. Hermine. 1998. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187: 961-966. [Abstract/Free Full Text]
  10. Larregina, A. T., A. E. Morelli, L. A. Spencer, A. J. Logar, S. C. Watkins, A. W. Thomson, L. D. Falo, Jr. 2001. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat. Immunol. 2: 1151-1158. [Medline]
  11. Piskin, G., R. M. Sylva-Steenland, J. D. Bos, M. B. Teunissen. 2006. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol. 176: 1908-1915. [Abstract/Free Full Text]
  12. Teunissen, M. B., G. Piskin, S. di Nuzzo, R. M. Sylva-Steenland, M. A. de Rie, J. D. Bos. 2002. Ultraviolet B radiation induces a transient appearance of IL-4+ neutrophils, which support the development of Th2 responses. J. Immunol. 168: 3732-3739. [Abstract/Free Full Text]
  13. de Jong, E. C., P. L. Vieira, P. Kalinski, J. H. Schuitemaker, Y. Tanaka, E. A. Wierenga, M. Yazdanbakhsh, M. L. Kapsenberg. 2002. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J. Immunol. 168: 1704-1709. [Abstract/Free Full Text]
  14. van der Ende, A., C. T. Hopman, S. Zaat, B. B. Essink, B. Berkhout, J. Dankert. 1995. Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter. J. Bacteriol. 177: 2475-2480. [Abstract/Free Full Text]
  15. Smits, H. H., A. Engering, K. D. van der Kleij, E. C. de Jong, K. Schipper, T. M. van Capel, B. A. Zaat, M. Yazdanbakhsh, E. A. Wierenga, Y. van Kooyk, M. L. Kapsenberg. 2005. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115: 1260-1267. [Medline]
  16. van Doornum, G. J., J. Guldemeester, A. D. Osterhaus, H. G. Niesters. 2003. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J. Clin. Microbiol. 41: 576-580. [Abstract/Free Full Text]
  17. Lebre, M. C., A. M. van der Aar, L. van Baarsen, T. M. van Capel, J. H. Schuitemaker, M. L. Kapsenberg, E. C. de Jong. 2007. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127: 331-341. [Medline]
  18. Magner, W. J., A. L. Kazim, C. Stewart, M. A. Romano, G. Catalano, C. Grande, N. Keiser, F. Santaniello, T. B. Tomasi. 2000. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J. Immunol. 165: 7017-7024. [Abstract/Free Full Text]
  19. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres, G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537. [Abstract/Free Full Text]
  20. Jarrossay, D., G. Napolitani, M. Colonna, F. Sallusto, A. Lanzavecchia. 2001. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31: 3388-3393. [Medline]
  21. Kadowaki, N., S. Ho, S. Antonenko, R. W. Malefyt, R. A. Kastelein, F. Bazan, Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869. [Abstract/Free Full Text]
  22. Girardin, S. E., I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D. J. Philpott, P. J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278: 8869-8872. [Abstract/Free Full Text]
  23. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, et al 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease. J. Biol. Chem. 278: 5509-5512. [Abstract/Free Full Text]
  24. Ogura, Y., N. Inohara, A. Benito, F. F. Chen, S. Yamaoka, G. Nunez. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-{kappa}B. J. Biol. Chem. 276: 4812-4818. [Abstract/Free Full Text]
  25. Napolitani, G., A. Rinaldi, F. Bertoni, F. Sallusto, A. Lanzavecchia. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6: 769-776. [Medline]
  26. Allan, R. S., C. M. Smith, G. T. Belz, A. L. van Lint, L. M. Wakim, W. R. Heath, F. R. Carbone. 2003. Epidermal viral immunity induced by CD8{alpha}+ dendritic cells but not by Langerhans cells. Science 301: 1925-1928. [Abstract/Free Full Text]
  27. Zhao, X., E. Deak, K. Soderberg, M. Linehan, D. Spezzano, J. Zhu, D. M. Knipe, A. Iwasaki. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197: 153-162. [Abstract/Free Full Text]
  28. Takeuchi, J., E. Watari, E. Shinya, Y. Norose, M. Matsumoto, T. Seya, M. Sugita, S. Kawana, H. Takahashi. 2003. Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells. Biochem. Biophys. Res. Commun. 306: 674-679. [Medline]
  29. Renn, C. N., D. J. Sanchez, M. T. Ochoa, A. J. Legaspi, C. K. Oh, P. T. Liu, S. R. Krutzik, P. A. Sieling, G. Cheng, R. L. Modlin. 2006. TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J. Immunol. 177: 298-305. [Abstract/Free Full Text]
  30. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779. [Abstract/Free Full Text]
  31. Menges, M., S. Rossner, C. Voigtlander, H. Schindler, N. A. Kukutsch, C. Bogdan, K. Erb, G. Schuler, M. B. Lutz. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor {alpha} induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195: 15-21. [Medline]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. Chamorro, J. J. Garcia-Vallejo, W. W. J. Unger, R. J. Fernandes, S. C. M. Bruijns, S. Laban, B. O. Roep, B. A. 't Hart, and Y. van Kooyk
TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program
J. Immunol., September 1, 2009; 183(5): 2984 - 2994.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. S. Duraisingham, J. Hornig, F. Gotch, and S. Patterson
TLR-Stimulated CD34 Stem Cell-Derived Human Skin-Like and Monocyte-Derived Dendritic Cells Fail to Induce Th17 Polarization of Naive T Cells but Do Stimulate Th1 and Th17 Memory Responses
J. Immunol., August 15, 2009; 183(4): 2242 - 2251.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Ogawa, T. Kawamura, T. Kimura, M. Ito, A. Blauvelt, and S. Shimada
Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation
Blood, May 21, 2009; 113(21): 5157 - 5166.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
O.V. Horst, K.A. Tompkins, S.R. Coats, P.H. Braham, R.P. Darveau, and B.A. Dale
TGF-{beta}1 Inhibits TLR-mediated Odontoblast Responses to Oral Bacteria
Journal of Dental Research, April 1, 2009; 88(4): 333 - 338.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. R. Mathers, B. M. Janelsins, J. P. Rubin, O. A. Tkacheva, W. J. Shufesky, S. C. Watkins, A. E. Morelli, and A. T. Larregina
Differential Capability of Human Cutaneous Dendritic Cell Subsets to Initiate Th17 Responses
J. Immunol., January 15, 2009; 182(2): 921 - 933.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Reske, G. Pollara, C. Krummenacher, D. R. Katz, and B. M. Chain
Glycoprotein-Dependent and TLR2-Independent Innate Immune Recognition of Herpes Simplex Virus-1 by Dendritic Cells
J. Immunol., June 1, 2008; 180(11): 7525 - 7536.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Peiser, J. Koeck, C. J. Kirschning, B. Wittig, and R. Wanner
Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity
J. Leukoc. Biol., May 1, 2008; 83(5): 1118 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Kumar, J. Yin, J. Zhang, and F.-S. X. Yu
Modulation of Corneal Epithelial Innate Immune Response to Pseudomonas Infection by Flagellin Pretreatment
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4664 - 4670.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C.-L. Ku, H. von Bernuth, C. Picard, S.-Y. Zhang, H.-H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al.
Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity
J. Exp. Med., October 1, 2007; 204(10): 2407 - 2422.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Aar, A. M.G.
Right arrow Articles by Teunissen, M. B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Aar, A. M.G.
Right arrow Articles by Teunissen, M. B. M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS